NCT00069940
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +33 more
- Locations
-
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Ependymoma
Explore clinical trials studying Ependymoma. Study availability and eligibility vary by location and protocol.
170 public trials
21 recruiting studies
Ependymoma trial results
NCT00049296
- Conditions
- AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
NCT00004892
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
- Locations
-
- University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University Hospital - Atlanta Atlanta, Georgia, United States
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00004028
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University Hospital - Atlanta Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Active, Not Recruiting
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
NCT04743661
- Conditions
- Ependymoma, Glioma, Medulloblastoma, +10 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT03155620
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
NCT02359565
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Active, Not Recruiting
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
NCT03220646
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) Hartford, Connecticut, United States
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
Active, Not Recruiting
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
NCT03213652
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +82 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States